Home > Publications . Search All . Browse All . Country . Browse PSC Pubs . PSC Report Series

PSC In The News

RSS Feed icon

Burgard and Seelye find job insecurity linked to psychological distress among workers in later years

Former PSC trainee Jay Borchert parlays past incarceration and doctoral degree into pursuing better treatment of inmates

Inglehart says shaky job market for millennials has contributed to their disaffection

More News

Highlights

Savolainen wins Outstanding Contribution Award for study of how employment affects recidivism among past criminal offenders

Giving Blueday at ISR focuses on investing in the next generation of social scientists

Pfeffer and Schoeni cover the economic and social dimensions of wealth inequality in this special issue

PRB Policy Communication Training Program for PhD students in demography, reproductive health, population health

More Highlights

Next Brown Bag

Mon, Jan 23, 2017 at noon:
H. Luke Shaefer

Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography

Archived Abstract of Former PSC Researcher

Burke, James, R. Albin, R. Koeppe, B. Giordani, M. Kilbourn, S. Gilman, and K. Frey. 2011. "Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography." Brain, 134: 1647-1657.

We assessed the relationship between consensus clinical diagnostic classification and neurochemical positron emission tomography imaging of striatal vesicular monoamine transporters and cerebrocortical deposition of a beta-amyloid in mild dementia. Seventy-five subjects with mild dementia (Mini-Mental State Examination score >= 18) underwent a conventional clinical evaluation followed by (11)C-dihydrotetrabenazine positron emission tomography imaging of striatal vesicular monoamine transporters and (11)C-Pittsburgh compound-B positron emission tomography imaging of cerebrocortical a beta-amyloid deposition. Clinical classifications were assigned by consensus of an experienced clinician panel. Neuroimaging classifications were assigned as Alzheimer's disease, frontotemporal dementia or dementia with Lewy bodies on the basis of the combined (11)C-dihydrotetrabenazine and (11)C-Pittsburgh compound-B results. Thirty-six subjects were classified clinically as having Alzheimer's disease, 25 as having frontotemporal dementia and 14 as having dementia with Lewy bodies. Forty-seven subjects were classified by positron emission tomography neuroimaging as having Alzheimer's disease, 15 as having dementia with Lewy bodies and 13 as having frontotemporal dementia. There was only moderate agreement between clinical consensus and neuroimaging classifications across all dementia subtypes, with discordant classifications in similar to 35% of subjects (Cohen's kappa = 0.39). Discordant classifications were least frequent in clinical consensus Alzheimer's disease (17%), followed by dementia with Lewy bodies (29%) and were most common in frontotemporal dementia (64%). Accurate clinical classification of mild neurodegenerative dementia is challenging. Though additional post-mortem correlations are required, positron emission tomography imaging likely distinguishes subgroups corresponding to neurochemically defined pathologies. Use of these positron emission tomography imaging methods may augment clinical classifications and allow selection of more uniform subject groups in disease-modifying therapeutic trials and other prospective research involving subjects in the early stages of dementia.

DOI:10.1093/brain/awr089 (Full Text)

Country of focus: United States of America.

Browse | Search : All Pubs | Next